[Delta]Np63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.

INTRODUCTION: Diagnosing non-small cell lung cancer on biopsy/cellblock samples by morphology may be demanding. As sparing material for molecular testing is mandatory, a minimalist immunohistochemistry (IHC)-based diagnostic approach is warranted by means of novel, reliable, and easy-to-assess bioma...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Thoracic Oncology Vol. 7; no. 2; pp. 281 - 291
Autores principales: Pelosi G, Fabbri A, Bianchi F, Maisonneuve P, Rossi G, Barbareschi M, Graziano P, Cavazza A, Rekhtman N, Pastorino U, Scanagatta P, Papotti M
Formato: Journal Article
Publicado: Elsevier B.V. 2012 Feb
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108163822&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 108163822
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15560864
        4Z2B
      jtl: Journal of Thoracic Oncology
      issn: 15560864
      maglogo: N
    pubinfo:
      dt: 2012 Feb
      vid: 7
      iid: 2
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        108163822
        2011473964
        NLM22071786
        108163822
      ppf: 281
      ppct: 10
      formats:
      tig:
        atl: [Delta]Np63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
      aug:
        au:
          Pelosi G
          Fabbri A
          Bianchi F
          Maisonneuve P
          Rossi G
          Barbareschi M
          Graziano P
          Cavazza A
          Rekhtman N
          Pastorino U
          Scanagatta P
          Papotti M
        affil: Department of Pathology and Laboratory Medicine,Fondazione IRCCS National Cancer Institute, Milan, Italy. giuseppe.pelosi@istitutotumori.mi.it
      sug:
        subj:
          Carcinoma, Non-Small-Cell Lung Classification
          Carcinoma, Non-Small-Cell Lung Metabolism
          Proteins Metabolism
          Lung Neoplasms Classification
          Lung Neoplasms Metabolism
          Adenocarcinoma Metabolism
          Adult
          Aged
          Neoplasms, Squamous Cell Metabolism
          Carcinoma, Squamous Cell Metabolism
          Female
          Immunoenzyme Techniques
          Male
          Middle Age
          Proteins
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
          Male
      ab: INTRODUCTION: Diagnosing non-small cell lung cancer on biopsy/cellblock samples by morphology may be demanding. As sparing material for molecular testing is mandatory, a minimalist immunohistochemistry (IHC)-based diagnostic approach is warranted by means of novel, reliable, and easy-to-assess biomarkers. METHODS: Forty-six consecutive biopsy/cellblock samples and the corresponding resection specimens (as the gold standard for morphology and IHC) from 30 adenocarcinomas (AD), 10 squamous carcinomas (SQC), 5 adenosquamous carcinomas (ADSQC), and 1 sarcomatoid carcinoma (SC) were IHC-evaluated for p40 [corresponding to nontransactivating [Delta]Np63 isoforms] and thyroid transcription factor-1 (TTF1) by semiquantitative assessment. For p40, also immunodecoration intensity was taken into account and dichotomized as strong or low. RESULTS: Nonrandom and overlapping distributions of the relevant markers were found in biopsy/cellblock and surgical specimens, which closely correlated with each other and the diverse tumor categories, with no differences in area under curve-receiver-operating-characteristic curves for each marker between any two samples, including p40 and p63. Diagnostic combinations were p40-/TTF1+ or TTF1- for AD (where p40 was negative, apart from 5/30 AD showing at the best 1-2% tumor cells with low intensity); p40+/TTF1- (p40 strong and by far higher than 50%) for SQC; and p40+/TTF1+ or p40+/TTF1- (p40 strong and less than 50%) for ADSQC. The single SC case was p40-/TTF1-, suggesting glandular lineage. Practically, 41/46 (89%) tumors were correctly classified by IHC on small samples, including 30 AD, 10 SQC, 1/5 ADSQC, and no SC. Underdiagnosis of ADSQC was actually because of sampling error of biopsies/cellblocks rather than insufficient biomarker robustness, whereas underdiagnosis of SC was really because of the failure of either marker to highlight epithelial-mesenchymal transition. CONCLUSIONS: This minimalist IHC-based model of p40 and TTF1 on biopsy/cellblock samples was effective to correctly subtype most cases of lung cancer.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N